Suchergebnisse - "Elliott, Jesse"

PubPharm (40)

1

Removing barriers to accessing medical cannabis for paediatric patients

enthalten in: Paediatrics & child health | 2024

von Huntsman, R. | Elliott, J. | Lewis, E. | +30

2

Crowd-sourcing and automation facilitated the identification and classification of randomized controlled trials in a living review

enthalten in: Journal of clinical epidemiology | 2023

von Kamso, M. | Pardo, J. | Whittle, S. | +10

3

Extended dual antiplatelet therapy following percutaneous coronary intervention in clinically important patient subgroups : a systematic review and meta-analysis

enthalten in: CMAJ open | 2023

von Elliott, J. | Kelly, S. | Bai, Z. | +4

4

Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy : A systematic review and network meta-analysis of randomized controlled trials

enthalten in: Diabetes/metabolism research and reviews | 2022

von Zheng, H. | Sigal, R. | Coyle, D. | +9

5

Comparative efficacy and safety of antihyperglycemic drug classes for patients with type 2 diabetes following failure with metformin monotherapy : A systematic review and network meta‐analysis of randomized controlled trials

enthalten in: Diabetes/Metabolism Research and Reviews | 2022

von Zheng, H. | Sigal, R. | Coyle, D. | +9

6

The Continued Need for Transparent Evidence on the Cost Effectiveness of Drugs for Rare Diseases

enthalten in: PharmacoEconomics | 2021

von Elliott, J. | Wells, G. | Coyle, D.

CommentOn: Pharmacoeconomics. 2021 Apr;39(4):473-475. - PMID 33674999

7

The Continued Need for Transparent Evidence on the Cost Effectiveness of Drugs for Rare Diseases

enthalten in: PharmacoEconomics | 2021

von Elliott, J. | Wells, G. | Coyle, D.

8

The Continued Need for Transparent Evidence on the Cost Effectiveness of Drugs for Rare Diseases

enthalten in: PharmacoEconomics | 2021

von Elliott, J. | Wells, G. | Coyle, D.

9

The Continued Need for Transparent Evidence on the Cost Effectiveness of Drugs for Rare Diseases

enthalten in: PharmacoEconomics | 2021

von Elliott, J. | Wells, G. | Coyle, D.

10

Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada : A qualitative study

enthalten in: Epilepsy & behavior : E&B | 2020

von Elliott, J. | DeJean, D. | Potter, B. | +4